AHIP, AMA, NAACOS Release Playbook for Value-Based Care

Three healthcare organizations, including AHIP, AMA, and NAACOS, have collaborated to release a playbook outlining best practices for value-based arrangements as the industry shifts away from fee-for-service models. The playbook focuses on improving patient experience, advancing population health, and reducing costs, with recommendations organized into seven domains. The goal is to help payers, physicians, hospitals,…

Read More

IgA Nephropathy Prognosis Worse With Microangiopathy

The presence of microangiopathy in patients with immunoglobulin A nephropathy (IgAN) is associated with a worse prognosis, as shown in a study of 450 patients. Patients with microangiopathy had a significantly increased risk for kidney outcomes, including a decrease in estimated filtration rate, end-stage kidney disease, kidney transplantation, or death. The group with microangiopathy also…

Read More

Public awareness campaign on risks of accessing weight loss surgery overseas is crucial

Surgeon Sala Abdalla warns about the risks of having surgery abroad, particularly in weight loss and cosmetic surgery. Patients are not adequately informed of the potential complications that can arise from medical procedures conducted outside their home country. Abdalla has personally treated multiple patients who experienced complications after undergoing surgery overseas. The rise of health…

Read More

Intestinal neurons in infancy could explain wide-ranging gastrointestinal disorders in children

A new theory proposed by Wu Tsai Neuro Faculty Scholar Julia Kaltschmidt and MD/Ph.D. candidate Lori Dershowitz suggests that defects in the organization of gut neurons in infancy may be linked to pediatric gastrointestinal motility disorders. This theory, published in a Perspective article in the journal Cellular and Molecular Gastroenterology and Hepatology, highlights the importance…

Read More

Study reveals novel approach to promote efficient uptake of ASOs into cancer cells

Antisense oligonucleotides (ASOs) are promising next-generation drugs that can block harmful messages from genes, potentially treating diseases like cancer. However, delivering ASOs into cancer cells has been a major challenge as the cells have gatekeeper molecules that prevent their entry. Researchers at Osaka University have developed a new compound called L687, which opens specific calcium…

Read More
error: Content is protected !!